Ad
related to: eplerenone 25 mg brand name- Savings & Affordability
Pay As Little As $0 If You Have
Commercial Insurance. *Terms Apply.
- Resources
Review Helpful Information About
Generalized Myasthenia Gravis.
- Savings & Affordability
Search results
Results From The WOW.Com Content Network
Eplerenone, sold under the brand name Inspra, ... Hence, 25 mg/day spironolactone may be equivalent to approximately 50 mg/day eplerenone. [25] Society and culture
Spironolactone 25 mg. Spironolactone, sold under the brand name Aldactone among others, is a diuretic medication primarily used to treat fluid build-up due to heart failure, liver scarring, or kidney disease. [4]
Eplerenone is a newer drug that was developed as a spironolactone analog with reduced adverse effects. In addition to the y-lactone ring and the substituent on C-7, eplerenone has a 9α,11α-epoxy group. This group is believed to be the reason why eplerenone has a 20-40-fold lower affinity for the mineralocorticoid receptor than spironolactone. [7]
The Calpol brand name is likely a combination of 'Calmic' and 'paracetamol'. [6] Calmic was acquired by Wellcome (today GlaxoSmithKline) in 1966, and Calpol became one of Wellcome's best-selling UK products in the 1980s. [6] The brand was later owned by Pfizer Consumer Healthcare, which was acquired by Johnson & Johnson in 2006. [7]
Esaxerenone (INN Tooltip International Nonproprietary Name) (brand name Minnebro; developmental code names CS-3150, XL-550) is a nonsteroidal antimineralocorticoid which was discovered by Exelixis and developed by Daiichi Sankyo Company and is approved in Japan for the treatment of hypertension.
Canrenone, sold under the brand names Contaren, Luvion, Phanurane, and Spiroletan, is a steroidal antimineralocorticoid [3] [4] of the spirolactone group related to spironolactone which is used as a diuretic in Europe, including in Italy and Belgium.
Finerenone, marketed under the brand name Kerendia 10 or 20 mg among others, is a medication used to reduce the risk of kidney function decline, kidney failure, cardiovascular death, non-fatal heart attacks, and hospitalization for heart failure in adults with chronic kidney disease associated with type 2 diabetes. [8]
Epalrestat is a carboxylic acid derivative [1] and a noncompetitive and reversible aldose reductase inhibitor used for the treatment of diabetic neuropathy, which is one of the most common long-term complications in patients with diabetes mellitus.
Ad
related to: eplerenone 25 mg brand name